author-photo

Uwe Pelzer

Humboldt University of Berlin

10

Papers

162

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.

2021 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (3)
Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma-Who Will Benefit from a Secondary Resection?

2021 Medicina-buenos Aires
Show All
- Source
- Cite
- Save
Citations (0)
TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (12)
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

2020 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (11)
671OConversion rate in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- or FOLFIRINOX-based induction chemotherapy (NEOLAP): Final results of a multicenter randomised phase II AIO trial

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (20)
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis

2018 Leukemia
Show All
- Source
- Cite
- Save
Citations (72)